BIOCRYST PHARMACEUTICALS, INC. Available-for-sale Securities, Fair Value Disclosure (Deprecated 2013-01-31)
BIOCRYST PHARMACEUTICALS, INC. (BCRX) had Available-for-sale Securities, Fair Value Disclosure (Deprecated 2013-01-31) of $13.46 million as of 2013-03-31, per its 10-Q filed 2013-05-09.
Discontinued › Notes › Investments
us-gaap:AvailableForSaleSecuritiesFairValueDisclosure · last filed 2013-05-09
- 2013-03-31: Available-for-sale Securities, Fair Value Disclosure (Deprecated 2013-01-31) $13.46M.
- 2012-12-31: Available-for-sale Securities, Fair Value Disclosure (Deprecated 2013-01-31) $15.86M.
- 2012-09-30: Available-for-sale Securities, Fair Value Disclosure (Deprecated 2013-01-31) $19.57M.
- 2012-06-30: Available-for-sale Securities, Fair Value Disclosure (Deprecated 2013-01-31) $29.31M.
| Period end | Available-for-sale Securities, Fair Value Disclosure (Deprecated 2013-01-31) |
|---|---|
| 2013-03-31 | $13.46M 10-Q · filed 2013-05-09 |
| 2012-12-31 | $15.86M 10-Q · filed 2013-05-09 |
| 2012-09-30 | $19.57M 10-Q · filed 2012-11-08 |
| 2012-06-30 | $29.31M 10-Q · filed 2012-08-08 |
| 2011-12-31 | $40.66M 10-K · filed 2013-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |